a public good project by the
Synthesis
Company
of California

© 2026

Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines | doi.page

0 citations0 references

Google Scholar doi.org

Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines

European Journal of Cancer·2010·Vol. 46(13), pp. 2389–2398

Citations Over TimeTop 12% of 2010 papers

Claire Falandry, Mario Campone, Guillaume Cartron, Daniel Guérin, Gilles Freyer

Related Papers

→ Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation(2016)15 cited
Sweet's syndrome associated with granulocyte colony-stimulating factor.(1996)
→ Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF; filgrastim) treatment of clozapine‐induced agranulocytosis(1993)25 cited
→ Recombinant Granulocyte Colony-Stimulating Factor Increases Muscle Strength in Neuromuscular Disorders(2013)1 cited
→ Granulocyte-Colony Stimulating Factor (G-CSF): Potential Financial Savings For German Hospitals(2017)